abrdn Healthcare Investors

Regulatory Filings • Aug 31, 2006

N-PX 1 a06-18934_1npx.htm ANNUAL REPORT OF PROXY VOTING RECORD

| UNITED
STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
| --- |
| OMB
Number: 3235-0582 |
| Expires: April 30, 2009 |
| Estimated
average burden hours per response......14.4 |

*FORM N-PX*

*ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY*

Investment Company Act file number 811- 04889

*H&Q Life Sciences Investors*

(Exact name of registrant as specified in charter)

30 Rowes Wharf, Boston, MA	02110
(Address of principal executive offices)	(Zip code)

*Kathleen Eckert H&Q Life Sciences Investors 30 Rowes Wharf, Boston MA 02110*

(Name and address of agent for service)

Registrant’s telephone number, including area code: 617 772-8500

Date of fiscal year end: September 30

Date of reporting period: 7/1/05 – 6/30/06

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

SEQ.=1,FOLIO='',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-be.htm',USER='pbalakrishnan',CD='Aug 31 14:16 2006'

*Item 1. Proxy Voting Record.*

SEQ.=1,FOLIO='',FILE='C:\JMS\svasudea\06-18934-1\task1344982\18934-1-bg.htm',USER='avchinnasamy',CD='Aug 31 00:09 2006'

*HQH N-PX for the period July 1, 2005 to June 30, 2006*

CUSIP	Symbol	Company Name
004225108	ACAD	Acadia
Pharmaceuticals, Inc.
Meeting Date:	6/13/2006	Meeting Type:	Annual
Record Date:	4/21/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Uli Hacksell	For	Yes	For	Management
1	Elect Director Torsten Rasmussen	For	Yes	For	Management
1	Elect Director Alan Walton	For	Yes	For	Management
2	To ratify the selection by the audit
committee of our board of directors of Pricewaterhousecoopers LLP as our
independent registered public accountanting firm for the fiscal year ending
December 31, 2006	For	Yes	For	Management

006864102 — Meeting Date:	ADZA — 6/6/2006
Record Date:	4/17/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Andrew E. Senyei, MD	For	Yes	For	Management
1	Elect Director Michael P. Downey	For	Yes	For	Management
2	To ratify the appointment of Ernst
& Young LLP as the company’s independent registered public accounting
firm for the fiscal year ending December 31, 2006	For	Yes	For	Management

00826T108 — Meeting Date:	AFFX — 6/15/2006
Record Date:	4/20/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Stephen P.A. Fodor,
Ph.D.	For	Yes	For	Management
1	Elect Director Paul Berg, Ph.D.	For	Yes	For	Management
1	Elect Director S.D. Desmond-Hellmann	For	Yes	For	Management
1	Elect Director John D. Diekman, Ph.D.	For	Yes	For	Management
1	Elect Director Vernon R. Loucks, Jr.	For	Yes	For	Management
1	Elect Director David B. Singer	For	Yes	For	Management
1	Elect Director Robert H. Trice, Ph.D.	For	Yes	For	Management
1	Elect Director John A. Young	For	Yes	For	Management
2	To ratify the appointment of Ernst
& Young LLP as the independent registered public accounting firm of the
company for the fiscal year ending December 31, 2006	For	Yes	For	Management

1

SEQ.=1,FOLIO='1',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Company Name
	Agilix Corporation
Action by Written
Consent:	8/29/2005

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Dominic J. Rodrigues	For	Yes	For	Management
2	Approval of changes associated with
one of the Company’s technologies	For	Yes	For	Management

	Agilix Corporation
Action by Written
Consent:	2/14/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve asset purchase agreement	For	Yes	For	Management

	Agilix Corporation
Action by Written
Consent:	4/7/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Authorize form, terms and provisions
of plan of liquidation	For	Yes	For	Management

009728106 — Meeting Date:	AKN — 5/25/2006
Record Date:	4/7/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director John N. Kapoor, Ph.D.	For	Yes	For	Management
1	Elect Director Arthur S. Przybyl	For	Yes	For	Management
1	Elect Director Jerry N. Ellis	For	Yes	For	Management
1	Elect Director Ronald M. Johnson	For	Yes	For	Management
1	Elect Director Jerry I. Treppel	For	Yes	For	Management
2	Proposal to ratify the selection of
BDO Seidman, LLP to serve as Akorn’s independent registered public accounting
firm for the fiscal year ending December 31, 2006	For	Yes	For	Management

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
016255101	ALGN	Align Technology,
Inc.
Meeting Date:	5/24/2006	Meeting Type:	Annual
Record Date:	3/31/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director H. Kent Bowen	For	Yes	For	Management
1	Elect Director David E. Collins	For	Yes	For	Management
1	Elect Director Joseph Lacob	For	Yes	For	Management
1	Elect Director C. Raymond Larkin, Jr.	For	Yes	For	Management
1	Elect Director George J. Morrow	For	Yes	For	Management
1	Elect Director Thomas M. Prescott	For	Yes	For	Management
1	Elect Director Greg J. Santora	For	Yes	For	Management
1	Elect Director Warren S. Thaler	For	Yes	For	Management
2	Ratification of selection of
independent registered public accountants: proposal to ratify the appointment
of Pricewatershousecoopers LLP as Align Technology, Inc.’s independent
registered public accountants for the fiscal year ending December 31, 2006.	For	Yes	For	Management

01642T108 — Meeting Date:	ALKS — 9/23/2005
Record Date:	7/26/2005

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Floyd E. Bloom	For	Yes	For	Management
1	Elect Director Robert A. Breyer	For	Yes	For	Management
1	Elect Director Gerri Henwood	For	Yes	For	Management
1	Elect Director Paul J. Mitchell	For	Yes	For	Management
1	Elect Director Richard F. Pops	For	Yes	For	Management
1	Elect Director Alexander Rich	For	Yes	For	Management
1	Elect Director Paul Schimmel	For	Yes	For	Management
1	Elect Director Mark B. Skaletsky	For	Yes	For	Management
1	Elect Director Michael A. Wall	For	Yes	For	Management
2	To approve an amendment to the 1999
stock option plan to increase to 19,900,000 the number of shares issuable
upon exercise of options granted thereunder, and increase of 3,000,000
shares.	For	Yes	For	Management

01988P108 — Meeting Date:	MDRX — 5/30/2006
Record Date:	4/12/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Philip D. Green	For	Yes	For	Management
1	Elect Director Bernard Goldstein	For	Yes	For	Management
1	Elect Director Marcel L. “Gus” Gamache	For	Yes	For	Management
2	Approval of the Allscripts Healthcare
Solutions, Inc. employee stock purchase plan	For	Yes	For	Management
3	Ratification of the appointment of
Grant Thornton LLP as independent accountants for 2006	For	Yes	For	Management

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
031162100	AMGN	Amgen, Inc.
Meeting Date:	5/10/2006	Meeting Type:	Annual
Record Date:	3/13/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Frederick W. Gluck	For	Yes	For	Management
1	Elect Director Adm. J. Paul Reason	For	Yes	For	Management
1	Elect Director Donald B. Rice	For	Yes	For	Management
1	Elect Director Leonard D. Schaeffer	For	Yes	For	Management
2	To ratify the selection of Ernst &
Young LLP as the company’s independent registered public accountants for the
year ending December 31, 2006	For	Yes	For	Management
3	Stockholder proposal #1 (stock
retention guidelines)	Against	Yes	Against	Shareholder
3	Stockholder proposal #2 (executive
compensation)	Against	Yes	Against	Shareholder
3	Stockholder proposal #3 (shareholder
rights plans)	Against	Yes	For	Shareholder
3	Stockholder proposal #4 (animal
welfare policy)	Against	Yes	Against	Shareholder
3	Stockholder proposal #5 (majority
elections)	Against	Yes	Against	Shareholder
3	Stockholder proposal #6 (corporate
political contributions)	For	Yes	For	Shareholder

04033A100 — Meeting Date:	ARIA — 6/14/2006
Record Date:	4/19/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Harvey J. Berger, MD	For	Yes	For	Management
1	Elect Director Michael D. Kishbauch	For	Yes	For	Management
1	Elect Director Burton E. Sobel, MD	For	Yes	For	Management
2	Approval of adoption of the 2006
long-term incentive plan and reservation of 4,500,000 shares of common stock
for stock options and other equity based grants which may be awarded under
the 2006 long-term incentive plan	For	Yes	For	Management
3	Ratification of selection of
independent registered public accounting firm: the audit committee of the
board of directors has selected Deloitte & Touche LLP to be our
independent registered public accounting firm for the year ending December
31, 2006.The board of directors has ratified this selection.	For	Yes	For	Management

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
05346P106	AVRX	Avalon Pharmaceuticals,
Inc.
Meeting Date:	6/9/2006	Meeting Type:	Annual
Record Date:	4/28/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director A.G. Walton, Ph.D.,
Dsc.	For	Yes	For	Management
1	Elect Director Kenneth C. Carter,
Ph.D.	For	Yes	For	Management
1	Elect Director Michael R. Kurman, MD	For	Yes	For	Management
1	Elect Director Bradley G. Lorimier	For	Yes	For	Management
1	Elect Director Ivor Royston, MD	For	Yes	For	Management
1	Elect Director William A. Scott, Ph.D.	For	Yes	For	Management
1	Elect Director Patrick Van Beneden	For	Yes	For	Management
1	Elect Director William H. Washecka	For	Yes	For	Management
1	Elect Director Raymond J. Whitaker,
Ph.D.	For	Yes	For	Management
2	To approve the amendment of the
company’s 2005 omnibus long-term incentive plan (the “incentive plan”) to
increase the number of shares available for issuance under the incentive plan
from 989,738 shares to 1,581,582 shares.	For	Yes	For	Management
3	To ratify the appointment of Ernst
& Young LLP as the company’s independent registered public accounting
firm for the fiscal year ending December 31, 2006	For	Yes	For	Management

| 05346P106 | Avalon
Pharmaceuticals, Inc. |
| --- | --- |
| Action by Written
Consent: | 8/4/2005 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Revision of Charter	For	No	None	Management
2	Revision of By-laws	For	No	None	Management
3	Adoption of 2005 equity incentive plan	For	No	None	Management

| 05346P106 | Avalon
Pharmaceuticals, Inc. |
| --- | --- |
| Action by Written
Consent: | 3/17/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve waiver of registration rights
to include shares of restricted stock in resale registration statement	For	No	None	Management

5

SEQ.=1,FOLIO='5',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
068306109	BRL	Barr Pharmaceuticals,
Inc.
Meeting Date:	11/3/2005	Meeting Type:	Annual
Record Date:	9/9/2005

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Bruce L. Downey	For	Yes	For	Management
1	Elect Director Paul M. Bisaro	For	Yes	For	Management
1	Elect Director Carole S. Ben-Maimon	For	Yes	For	Management
1	Elect Director George Stephan	For	Yes	For	Management
1	Elect Director Jack M. Kay	For	Yes	For	Management
1	Elect Director Harold N. Chefitz	For	Yes	For	Management
1	Elect Director Richard R. Frankovic	For	Yes	For	Management
1	Elect Director Peter R. Seaver	For	Yes	For	Management
1	Elect Director James S. Gilmore, III	For	Yes	For	Management
2	Increase of authorized shares for the
Barr Pharmaceuticals, Inc. employee stock purchase plan.	For	Yes	For	Management
3	Ratification of the selection of
Deloitte & Touche LLP as the registered public accounting firm of the
company for the fiscal year ending June 30, 2006	For	Yes	For	Management
4	Elimination of animal based test
methods.	Against	Yes	Against	Shareholder

06850R108 — Meeting Date:	BRTX — 6/21/2006
Record Date:	4/24/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Carl W. Ehmann, MD	For	Yes	For	Management
1	Elect Director Peter Ernster	For	Yes	For	Management
1	Elect Carol Raphael	For	Yes	For	Management
2	To ratify the appointment of Ernst
& Young LLP as the independent registered public accounting firm of the
company for the fiscal year ending December 31, 2006	For	Yes	For	Management

09062X103 — Meeting Date:	BIIB — 5/25/2006
Record Date:	3/31/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Lawrence C. Best	For	Yes	For	Management
1	Elect Director Alan B. Glassberg	For	Yes	For	Management
1	Elect Director Robert W. Pangia	For	Yes	For	Management
1	Elect Director William D. Young	For	Yes	For	Management
2	To ratify the selection of
Pricewaterhousecoopers LLP as the company’s independent registered public
accounting firm for the fiscal year ending December 31, 2006	For	Yes	For	Management
3	To approve our 2006 non-employee directors
equity plan	For	Yes	For	Management

6

SEQ.=1,FOLIO='6',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
101137107	BSX	Boston Scientific
Corporation
Meeting Date:	3/31/2006	Meeting Type:	Special
Record Date:	2/22/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	To adopt an amendment to the company’s
second restated certificate of incorporation, as amended, to increase the
authorized number of shares of common stock of the company from 1,200,000,000
to 2,000,000,000.	For	Yes	For	Management
2	To approve the issuance of shares of
common stock of the company to the shareholders of Guidant Corporation
pursuant to the terms of the merger agreement, dated as of January 25, 2006, between
the company, Galaxy Merger Sub, Inc. and Guidant Corporation.	For	Yes	For	Management

101137107 — Meeting Date:	BSX — 5/9/2006
Record Date:	3/17/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director John E. Abele	For	Yes	For	Management
1	Elect Director Joel L. Fleishman	For	Yes	For	Management
1	Elect Director Ernest Mario, Ph.D.	For	Yes	For	Management
1	Elect Director Uwe E. Reinhardt	For	Yes	For	Management
2	Election of Director Nancy-Ann Deparle	For	Yes	For	Management
2	Election of Director Kristina M.
Johnson, Ph.D.	For	Yes	For	Management
3	Ratification of Ernst & Young LLP
as indpendent auditors	For	Yes	For	Management
4	To approve the Boston Scientific
Corporation 2006 global employee stock ownership plan	For	Yes	For	Management

	CardioNet, Inc.
Action by Written
Consent:	8/15/2005

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Authorize and approve bridge financing
and amendment with the Secretary of the State of California	For	Yes	For	Management
2	Waive of rights of first offer	For	Yes	For	Management
3	Authorize appropriate officers of the
Company to make filings and applications	For	Yes	For	Management
4	Ratify, approve and confirm all
actions of the officers of the Company in connection with the amendment and
bridge financing	For	Yes	For	Management

7

SEQ.=1,FOLIO='7',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Company Name
	CardioNet, Inc.
Action by Written
Consent:	1/26/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Harry T. Rein	For	Yes	For	Management

	CardioNet, Inc.
Action by Written
Consent:	2/20/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Consent to extension of maturity date	For	Yes	For	Management

	CardioNet, Inc.
Action by Written
Consent:	3/31/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Bruce KenKnight	For	Yes	For	Management

	CardioNet, Inc.
Action by Written
Consent:	5/1/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Authorize and approve Bridge Financing	For	Yes	For	Management
2	Waive of Rights of First Offer	For	Yes	For	Management
3	Authorize appropriate officers of the
Company to make filings and applications	For	Yes	For	Management
4	Ratify, approve and confirm all
actions of the officers of the Company in connection with the amendment and
bridge financing	For	Yes	For	Management

N/A — Meeting Date:	N/A — 7/18/2006
Record Date:	6/28/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Walter De Logi	For	Yes	For	Management
1	Elect Director Pascal Brandys	For	Yes	For	Management
1	Elect Director Frank Bulens	For	Yes	For	Management
1	Elect Director Raymond Debbane	For	Yes	For	Management
1	Elect Director Robert Goldberg	For	Yes	For	Management
1	Elect Director Richard Hamilton	For	Yes	For	Management
1	Elect Director Thomas Kiley	For	Yes	For	Management
1	Elect Director Edmund Olivier	For	Yes	For	Management
1	Elect Director Floris Vansina	For	Yes	For	Management
2	Ratification of appointment of KPMG
LLP as independent public accountants	For	Yes	For	Management

8

SEQ.=1,FOLIO='8',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Company Name
	Concentric Medical,
Inc.
Action by Written
Consent:	7/22/2005

#	Proposal	Mgt. Recommends	Voted	Sponsor
1	Elect Direct Edward Unkart	For	No	Management
1	Omnibus resolution	For	No	Management

208264101 — Meeting Date:	CONR — 6/21/2006
Record Date:	4/25/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director John F. Shanley	For	Yes	For	Management
1	Elect Director Steven B. Gerber, MD	For	Yes	For	Management
2	To ratify the selection of Ernst &
Young LLP as Conor Medsystems’ independent registered public accounting firm
for the fiscal year ending December 31, 2006	For	Yes	For	Management

	Corus Pharma, Inc.
Action by Written
Consent:	4/10/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve amendment and restatement of
certificate of incorporation	For	Yes	For	Management
2	Approve amendment to 2001 stock plan	For	Yes	For	Management

	Corus Pharma, Inc.
Action by Written
Consent:	4/11/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Adoption of agreement and plan of
merger	For	No	None	Management

229678107 — Meeting Date:	CBST — 6/8/2006
Record Date:	4/12/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director David W. Martin, Jr.	For	Yes	For	Management
1	Elect Director Kenneth M. Bate	For	Yes	For	Management
2	Ratify the selection of
Pricewaterhousecoopers LLP as our independent auditor for the fiscal year
ending December 31, 2006	For	Yes	For	Management
3	Ratify, adopt and approve the amended
and restated 2002 directors’ equity incentive plan.	For	Yes	For	Management

9

SEQ.=1,FOLIO='9',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
249908104	DEPO	Depomed, Inc.
Meeting Date:	6/9/2006	Meeting Type:	Annual
Record Date:	4/21/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director John W. Fara, Ph.D.	For	Yes	For	Management
1	Elect Director G. Steven Burrill	For	Yes	For	Management
1	Elect Director Gerald T. Proehl	For	Yes	For	Management
1	Elect Director John W. Shell, Ph.D.	For	Yes	For	Management
1	Elect Director Craig R. Smith, MD	For	Yes	For	Management
1	Elect Director Peter D. Staple	For	Yes	For	Management
1	Elect Director Julian N. Stern	For	Yes	For	Management
2	To ratify the appointment of Ernst
& Young LLP as the independent registered public accounting firm of the
company for the fiscal year ending December 31, 2006	For	Yes	For	Management

23325G104 — Meeting Date:	DJO — 6/7/2006
Record Date:	4/21/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Charles T. Orsatti	For	Yes	For	Management
1	Elect Director Lewis Parker	For	Yes	For	Management
2	To ratify the appointment of Ernst
& Young LLP as the company’s independent registered public accounting
firm for the fiscal year ending December 31, 2006	For	Yes	For	Management

259858108 — Meeting Date:	DOVP — 5/22/2006
Record Date:	4/5/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Daniel S. Van Riper	For	Yes	For	Management
1	Elect Director Dennis G. Podlesak	For	Yes	For	Management
2	To approve an amendment to the company’s
2000 stock option and grant plan to increase the total number of shares of
common stock authorized for issuance under the plan by 1,000,000 to 4,692,090
from 3,692,090	For	Yes	For	Management
3	To ratify the selection of
Pricewaterhousecoopers LLP as independent registered public accounting firm
for its fiscal year ending December 31, 2006	For	Yes	For	Management

10

SEQ.=1,FOLIO='10',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
278856109	ECLP	Eclipsys Corporation
Meeting Date:	5/10/2006	Meeting Type:	Annual
Record Date:	3/15/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Steven A. Denning	For	Yes	For	Management
1	Elect Director Jay B. Pieper	For	Yes	For	Management
2	To ratify the selection by the board
of directors of Pricewaterhousecoopers LLP as the company’s registered public
accounting firm for the current fiscal year.	For	Yes	For	Management

29076V109 — Meeting Date:	EMAG — 5/25/2006
Record Date:	4/21/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Roddy J.H. Clark	For	Yes	For	Management
1	Elect Director John W. Thompson	For	Yes	For	Management
2	Proposal to ratify the appointment of
Ernst & Young LLP as the company’s independent registered public acocunting
firm for the current fiscal year.	For	Yes	For	Management

290849108 — Meeting Date:	HLTH — 9/29/2005
Record Date:	8/5/2005

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Neil F. Dimick	For	Yes	For	Management
1	Elect Director Joseph E. Smith	For	Yes	For	Management
2	To approve an amendment to WebMD’s
certification of incorporation to change the coporate name of WebMD to Emdeon
Corporation.	For	Yes	For	Management
3	To ratify the appointment of Ernst
& Young LLP as the independent registered public accounting firm to serve
as WebMD’s independent auditor for the fiscal year ending December 31, 2005.	For	Yes	For	Management

11

SEQ.=1,FOLIO='11',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
29256X107	ENCY	Encysive
Pharmaceuticals, Inc.
Meeting Date:	5/12/2006	Meeting Type:	Annual
Record Date:	3/30/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director John M. Pietruski	For	Yes	For	Management
1	Elect Director Ron J. Anderson	For	Yes	For	Management
1	Elect Director J. Kevin Buchi	For	Yes	For	Management
1	Elect Director Robert J. Cruikshank	For	Yes	For	Management
1	Elect Director John H. Dillon, II	For	Yes	For	Management
1	Elect Director Richard A.F. Dixon	For	Yes	For	Management
1	Elect Director Bruce D. Given	For	Yes	For	Management
1	Elect Director Suzanne Oparil	For	Yes	For	Management
1	Elect Director James A. Thomson	For	Yes	For	Management
1	Elect Director James T. Willerson	For	Yes	For	Management

29264F205 — Meeting Date:	ENDP — 5/30/2006
Record Date:	4/19/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Carol A. Ammon	For	Yes	For	Management
1	Elect Director John J. Delucca	For	Yes	For	Management
1	Elect Director Michel De Rosen	For	Yes	For	Management
1	Elect Director Michael Hyatt	For	Yes	For	Management
1	Elect Director Roger H. Kimmel	For	Yes	For	Management
1	Elect Director Peter A. Lankau	For	Yes	For	Management
1	Elect Director C.A. Meanwell, MD,
Ph.D.	For	Yes	For	Management
1	Elect Director J.T. O’Donnell, Jr.	For	Yes	For	Management
2	To ratify the appointment of Deloitte
& Touche LLP as the independent registered public accounting firm for the
company’s fiscal year ending December 31, 2006	For	Yes	For	Management

30161Q104 — Meeting Date:	EXEL — 5/1/2006
Record Date:	3/3/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Charles Cohen, Ph.D.	For	Yes	For	Management
1	Elect Director George Poste, DVM,
Ph.D.	For	Yes	For	Management
1	Elect Director Jack Wyszomierski	For	Yes	For	Management
2	To ratify the selection of Ernst &
Young LLP as the company’s independent registered public accounting firm for
the fiscal year ending Dec. 31, 2006	For	Yes	For	Management

12

SEQ.=1,FOLIO='12',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
345838109	FRX	Forest Laboratories,
Inc.
Meeting Date:	8/8/2005	Meeting Type:	Annual
Record Date:	6/21/2005

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Howard Solomon	For	Yes	For	Management
1	Elect Director William J. Candee, III	For	Yes	For	Management
1	Elect Director George S. Cohan	For	Yes	For	Management
1	Elect Director Dan L. Goldwasser	For	Yes	For	Management
1	Elect Director Lester B. Salans	For	Yes	For	Management
1	Elect Director Kenneth E. Goodman	For	Yes	For	Management
1	Elect Director Phillip M. Satow	For	Yes	For	Management
2	Ratification of BDO Seidman, LLP as
independent registered public accounting firm.	For	Yes	For	Management

Galileo Pharmaceuticals, Inc.

*Action by Written Consent:*

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect to liquidate affairs of the
Company	For	Yes	For	Management

36866T103 — Meeting Date:	GPRO — 5/17/2006
Record Date:	3/24/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director John W. Brown	For	Yes	For	Management
1	Elect Director Henry L. Nordhoff	For	Yes	For	Management
2	To approve an amendment to the 2003 incentive
award plan of the company to increase the number of shares of common stock
authorized for issuance by 3,000,000 shares	For	Yes	For	Management
3	To ratify the selection of Ernst &
Young LLP as the company’s independent registered public accounting firm for
the fiscal year endind December 31, 2006	For	Yes	For	Management

13

SEQ.=1,FOLIO='13',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
368710406	DNA	Genentech, Inc.
Meeting Date:	4/20/2006	Meeting Type:	Annual
Record Date:	2/22/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Herbrt W. Boyer	For	Yes	For	Management
1	Elect Director William M. Burns	For	Yes	For	Management
1	Elect Director Erich Hunziker	For	Yes	For	Management
1	Elect Director Jonathan K.C. Knowles	For	Yes	For	Management
1	Elect Director Arthur D. Levinson	For	Yes	For	Management
1	Elect Director Debra L. Reed	For	Yes	For	Management
1	Elect Director Charles A. Sanders	For	Yes	For	Management
2	To approve an amendment to the 1991
employee stock plan	For	Yes	For	Management
3	To ratify the selection of Ernst &
Young LLP as independent registered public accounting firm of Genentech for
the year ending December 31, 2006.	For	Yes	For	Management

372917104 — Meeting Date:	GENZ — 5/25/2006
Record Date:	3/31/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Dr. Victor Dzau	For	Yes	For	Management
1	Elect Director Senator Connie Mack	For	Yes	For	Management
1	Elect Director Henri A. Termeer	For	Yes	For	Management
2	A proposal to amend the 2004 equity
incentive plan to provide for the grant of restricted stock and restricted
stock units and increase the number of shares of common stock covered by the
plan by 7,000,000 shares	For	Yes	For	Management
3	A proposal to amend the 1998 director
stock option plan to increase the number of shares of common stock covered by
the plan by 300,000 shares	For	Yes	For	Management
4	The amendment and restatement of our
restated articles of organization to declassify our board so that, beginning
in 2007, all directors are elected for one year terms	For	Yes	For	Management
5	A proposal to ratify the selection of
independent auditors for 2006	For	Yes	For	Management
6	A shareholder proposal that executive
severance arrangements be approved by shareholder	Against	Yes	Against	Shareholder

14

SEQ.=1,FOLIO='14',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
375558103	GILD	Gilead Sciences, Inc.
Meeting Date:	5/10/2006	Meeting Type:	Annual
Record Date:	3/22/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Paul Berg	For	Yes	For	Management
1	Elect Director John F. Cogan	For	Yes	For	Management
1	Elect Director Etienne F. Davignon	For	Yes	For	Management
1	Elect Director James M. Denny	For	Yes	For	Management
1	Elect Director John W. Madigan	For	Yes	For	Management
1	Elect Director John C. Martin	For	Yes	For	Management
1	Elect Director Gordon E. Moore	For	Yes	For	Management
1	Elect Director Nicholas G. Moore	For	Yes	For	Management
1	Elect Director Gayle E. Wilson	For	Yes	For	Management
2	To ratify the selection of Ernst &
Young LLP by the audit committee of the board of directors as the independent
registered public accounting firm of Gilead for the fiscal year ending
December 31, 2006.	For	Yes	For	Management
3	To approve an amendment to Gilead’s
2004 equity incentive plan	For	Yes	For	Management
4	To approve Gilead’s code section
162(M) bonus plan and certain performance-based provisions thereunder.	For	Yes	For	Management
5	To approve an amendment to Gilead’s
restated certificate of incorporation to increase the authorized number of
shares of Gilead’s common stock from 700,000,000 to 1,400,000,000 shares.	For	Yes	For	Management
6	To approve a stockholder proposal
requesting a report on the HIV/AIDS, tuberculosis, and malaria pandemic	Against	Yes	Against	Shareholder

401698105 — Meeting Date:	GDT — 3/31/2006
Record Date:	2/22/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	To approve the agreement and plan of
merger, dated as of January 25, 2006, among Boston Scientific Corporation,
Galaxy Merger Sub, Inc., a wholly owned subsidiary of Boston Scientific
Corporation, and Guidant Corporation, pursuant to which Galaxy Merger Sub,
Inc. will merge with and into Guidant Corporation, all as more fully
described in the proxy statement/prospectus.	For	Yes	For	Management

15

SEQ.=1,FOLIO='15',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-01.htm',USER='pbalakrishnan',CD='Aug 31 14:12 2006'

CUSIP	Symbol	Company Name
45069D203	DMX	I-trax,
Inc.
Meeting
Date:	5/17/2006	Meeting
Type:	Annual
Record
Date:	3/29/2006

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Haywood D.
Cochrane, Jr. | For | Yes | For | Management |
| 1 | Elect Director Philip D.
Green | For | Yes | For | Management |
| 1 | Elect Director Gail F.
Lieberman | For | Yes | For | Management |
| 1 | Elect Director Frank A.
Martin | For | Yes | For | Management |
| 1 | Elect Director Gerald D. Mintz | For | Yes | For | Management |
| 1 | Elect Director David Nash,
MD | For | Yes | For | Management |
| 1 | Elect Director Jack A.
Smith | For | Yes | For | Management |
| 1 | Elect Director R. Dixon
Thayer | For | Yes | For | Management |
| 2 | To ratify the appointment
of Goldstein Golub Kessler LLP as the Company’s independent auditors for the
fiscal year ending December 31, 2006. | For | Yes | For | Management |

| 45166R204 — Meeting
Date: | IDIX — 6/14/2006 |
| --- | --- |
| Record
Date: | 4/18/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director J-P.
Sommadossi, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Charles W.
Cramb | For | Yes | For | Management |
| 1 | Elect Director Thomas
Ebeling | For | Yes | For | Management |
| 1 | Elect Director W.T.
Hockmeyer, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Thomas R.
Hodgson | For | Yes | For | Management |
| 1 | Elect Director Robert E.
Pelzer | For | Yes | For | Management |
| 1 | Elect Director D.
Pollard-Knight, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Pamela
Thomas-Graham | For | Yes | For | Management |
| 2 | To ratify the selection of
Pricewaterhousecoopers LLP as the company’s independent registered public
accounting firm for the current fiscal year ending December 31, 2006 | For | Yes | For | Management |

| 45168D104 — Meeting
Date: | IDXX — 5/10/2006 |
| --- | --- |
| Record
Date: | 3/20/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director William T.
End | For | Yes | For | Management |
| 1 | Elect Director Barry C.
Johnson, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Brian P.
Mckeon | For | Yes | For | Management |
| 2 | To approve an amendment to
the company’s restated certificate of incorporation increasing the number of
authorized shares of common stock form 60,000,000 to 120,000,000 | For | Yes | For | Management |
| 3 | Ratification of
appointment of independent registered public accounting firm. To ratify the
selection by the audit committee of the board of directors of of
pricewaterhousecoopers LLP as the company’s independent registered public
accounting firm for the current fiscal year. | For | Yes | For | Management |

16

SEQ.=1,FOLIO='16',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
45719T103	INHX	Inhibitex,
Inc.
Meeting
Date:	5/18/2006	Meeting
Type:	Annual
Record
Date:	3/31/2006

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Carl E.
Brooks | For | Yes | For | Management |
| 1 | Elect Director Robert A.
Hamm | For | Yes | For | Management |
| 1 | Elect Director Louis W.
Sullivan | For | Yes | For | Management |
| 2 | Ratification of the
appointment of Ernst & Young LLP as the independent registered public
accounting firm for Inhibitex, Inc. | For | Yes | For | Management |

| 457669208 — Meeting
Date: | INSM — 5/10/2006 |
| --- | --- |
| Record
Date: | 3/17/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Geoffrey
Allan, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Melvin
Sharoky, MD | For | Yes | For | Management |
| 1 | Elect Director Randall W.
Whitcomb, MD | For | Yes | For | Management |
| 2 | Ratification of the
selection of Ernst & Young LLP as the independent auditors for Insmed for
the fiscal year ending December 31, 2006. | For | Yes | For | Management |

| 457733103 — Meeting
Date: | ISPH — 6/13/2006 |
| --- | --- |
| Record
Date: | 4/17/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Alan F.
Holmer | For | Yes | For | Management |
| 1 | Elect Director William R.
Ringo, Jr. | For | Yes | For | Management |
| 2 | Ratification of selection
of Pricewaterhousecoopers LLP as our independent registered public accounting
firm for the fiscal year ending December 31, 2006 | For | Yes | For | Management |
| 3 | Approval of a proposal to
amend and restate our restated certificate of incorporation to increase the
total authorized shares of common stock, par value $0.001 per share, of the
company from 60,000,000 to 100,000,000 | For | Yes | For | Management |

17

SEQ.=1,FOLIO='17',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
461169104	ILSE	Intralase
Corporation
Meeting
Date:	7/20/2005	Meeting Type:	Annual
Record
Date:	6/24/2005

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Thomas S.
Porter | For | Yes | For | Management |
| 1 | Elect Director Jay T.
Holmes | For | Yes | For | Management |
| 2 | To ratify the selection of
Deloitte & Touche, LLP as independent auditors of the company for its
fiscal year ending December 31, 2005. | For | Yes | For | Management |

| 465823102 — Meeting
Date: | IVX — 8/3/2005 |
| --- | --- |
| Record
Date: | 4/29/2005 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Betty G.
Amos | For | Yes | For | Management |
| 1 | Elect Director Mark
Andrews | For | Yes | For | Management |
| 1 | Elect Director Jack
Fishman, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Neil
Flanzraich | For | Yes | For | Management |
| 1 | Elect Director Phillip
Frost, M.D. | For | Yes | For | Management |
| 1 | Elect Director Jane Hsiao,
Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Richard M.
Krasno, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director David A.
Lieberman | For | Yes | For | Management |
| 1 | Elect Director Richard C.
Pfenniger, Jr. | For | Yes | For | Management |
| 1 | Elect Director Bertram
Pitt, M.D. | For | Yes | For | Management |
| 1 | Elect Director Z.P.
Zachariah, M.D. | For | Yes | For | Management |

| 465823102 — Meeting
Date: | IVX — 10/27/2005 |
| --- | --- |
| Record
Date: | 9/30/2005 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | To approve the agreement
and plan of merger, dated as of July 25, 2005, by and among Ivax Corporation,
Teva Pharmaceuticals Industries Ltd., Ivory Acquisition Sub, Inc. and Ivory
Acquisition Sub II, Inc. | For | Yes | For | Management |

18

SEQ.=1,FOLIO='18',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
50064W107	KOSN	Kosan
Biosciences, Inc.
Meeting
Date:	5/25/2006	Meeting
Type:	Annual
Record
Date:	3/31/2006

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Kevan Clemens,
Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Jean
Deleage, Ph.D. | For | Yes | For | Management |
| 2 | Approval of 2006 equity
incentive plan | For | Yes | For | Management |
| 3 | Ratification of selection
of independent registered public accounting firm | For | Yes | For | Management |

| | Masimo
Corporation |
| --- | --- |
| Action by
Written Consent: | 8/29/2005 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | To approve the amendment
to the cross-licensing agreement between Masimo Corporation and Masimo
Laboratories. | For | Yes | For | Management |

| | Masimo
Corporation |
| --- | --- |
| Action by
Written Consent: | 2/28/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | To approve an amendment to
the Corporation’s Amended and Restated Certificate of Incorporation | For | Yes | For | Management |
| 2 | To approve an amendment to
the Corporation’s 2004 Incentive Stock Option, Nonqualified Stock Option and
Restricted Stock Purchase Plan | For | Yes | For | Management |

| 58405U102 — Meeting
Date: | MHS — 5/24/2006 |
| --- | --- |
| Record
Date: | 3/29/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Lawrence S.
Lewin | For | Yes | For | Management |
| 1 | Elect Director Charles M.
Lillis | For | Yes | For | Management |
| 1 | Elect Director Edward H.
Shortliffe | For | Yes | For | Management |
| 1 | Elect Director David D.
Stevens | For | Yes | For | Management |
| 2 | To ratify the appointment
of Pricewaterhousecoopers LLP as the independent registered public accounting
firm of the company for the fiscal year ending December 30, 2006. | For | Yes | For | Management |

19

SEQ.=1,FOLIO='19',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
584690309	MRX	Medicis
Pharmaceutical Corporation
Meeting
Date:	12/19/2005	Meeting
Type:	Annual
Record
Date:	11/4/2005

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Approval of the issuance
of shares of Medicis Class A Common Stock, pursuant to the agreement and plan
of merger, dated as of March 20, 2005, by and among Medicis Pharmaceutical
Corp., Masterpiece Acquisition Corp., a wholly-owned subsidiary of Medicis,
and Inamed Corporation. | For | Yes | For | Management |
| 2 | Approval of an amendment
to Medicis’ certificate of incorporation to increase the number of authorized
shares of Medicis common stock from 150,000,000 to 300,000,000 and change
Medicis’ name from “Medicis Pharmaceutical Corporation” to “Medicis”. | For | Yes | For | Management |
| 3 | Elect Director Spencer
Davidson | For | Yes | For | Management |
| 3 | Elect Director Stuart
Diamond | For | Yes | For | Management |
| 3 | Elect Director Peter S.
Knight, ESQ. | For | Yes | For | Management |
| 4 | Ratification of the
selection of Ernst & Young LLP as independent auditors of Medicis for the
fiscal year ending June 30, 2006 and any interim periods resulting from a
change to Medicis’ fiscal year-end | For | Yes | For | Management |
| 5 | Adjournment of the Medicis
annual meeting, if necessary, to permit further solicitation of proxies if
there are not sufficient votes at the time of the Medicis annual meeting in
favor of the foregoing | For | Yes | For | Management |

| 584690309 — Meeting
Date: | MRX — 5/23/2006 |
| --- | --- |
| Record Date: | 3/30/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Arthur G.
Altschul, Jr. | For | Yes | For | Management |
| 1 | Elect Director Philip S.
Schein, MD | For | Yes | For | Management |
| 2 | Approval of the Medicis
2006 incentive award plan | For | Yes | For | Management |
| 3 | Ratification of the
selection of Ernst & Young LLP as independent auditors of Medicis for the
fiscal year ending December 31, 2006 | For | Yes | For | Management |

| 584699102 — Meeting
Date: | MEDI — 5/25/2006 |
| --- | --- |
| Record
Date: | 3/31/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Wayne T.
Hockmeyer | For | Yes | For | Management |
| 1 | Elect Director David M.
Mott | For | Yes | For | Management |
| 1 | Elect Director David
Baltimore | For | Yes | For | Management |
| 1 | Elect Director M. James
Barrett | For | Yes | For | Management |
| 1 | Elect Director James H.
Cavanaugh | For | Yes | For | Management |
| 1 | Elect Director Barbara H.
Franklin | For | Yes | For | Management |
| 1 | Elect Director Gordon S.
Macklin | For | Yes | For | Management |
| 1 | Elect Director George M.
Milne, Jr. | For | Yes | For | Management |
| 1 | Elect Director Elizabeth
H.S. Wyatt | For | Yes | For | Management |
| 2 | To approve an amendment to
the 2003 non-employee directors stock option plan | For | Yes | For | Management |
| 3 | To approve and ratify the
appointment of Pricewaterhousecoopers LLP as independent registered public
accounting form for 2006 | For | Yes | For | Management |

20

SEQ.=1,FOLIO='20',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
585055106	MDT	Medtronic,
Inc.
Meeting
Date:	8/25/2005	Meeting
Type:	Annual
Record
Date:	7/1/2005

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Shirley A.
Jackson, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Denise M.
O’Leary | For | Yes | For | Management |
| 1 | Elect Director Jean-Pierre
Rosso | For | Yes | For | Management |
| 1 | Elect Director Jack W.
Schuler | For | Yes | For | Management |
| 2 | To ratify the appointment
of Pricewaterhousecoopers LLP as Medtronic’s independent registered public
accounting firm | For | Yes | For | Management |
| 3 | To approve the Medtronic,
Inc. 2005 employee stock purchase plan | For | Yes | For | Management |
| 4 | To approve the Medtronic,
Inc. 1998 outside director’s stock compensation plan (as amended and
restated) | For | Yes | For | Management |

| 552880106 — Meeting
Date: | MOGN — 5/9/2006 |
| --- | --- |
| Record
Date: | 3/13/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Andrew J.
Ferrara | For | Yes | For | Management |
| 1 | Elect Director Edward W.
Mehrer | For | Yes | For | Management |
| 1 | Elect Director Hugh E.
Miller | For | Yes | For | Management |
| 1 | Elect Director Dean J.
Mitchell | For | Yes | For | Management |
| 1 | Elect Director Leon O.
Moulder, Jr. | For | Yes | For | Management |
| 1 | Elect Director David B.
Sharrock | For | Yes | For | Management |
| 1 | Elect Director Waneta C.
Tuttle, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Arthur L.
Weaver, MD | For | Yes | For | Management |
| 2 | To approve the amended and
restated 1997 stock incentive plan (“the incentive plan”) to, among other
things, increase the number of shares available for issuance under the
incentive plan by 7,400,000 shares. | For | Yes | Against | Management |
| 3 | To ratify the appointment
of KPMG LLP as independent registered public accounting firm for the company
for the fiscal year ending December 31, 2006 | For | Yes | For | Management |

21

SEQ.=1,FOLIO='21',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
60877T100	MNTA	Momenta
Pharmaceuticals, Inc.
Meeting
Date:	6/15/2006	Meeting
Type:	Annual
Record
Date:	4/25/2006

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director John K.
Clarke | For | Yes | For | Management |
| 1 | Elect Director Robert S.
Langer, Jr. | For | Yes | For | Management |
| 1 | Elect Director Stephen T.
Reeders | For | Yes | For | Management |
| 2 | To ratify the selection by
the board of directors of Ernst & Young LLP as the company’s independent
auditors for the fiscal year ending December 31, 2006 | For | Yes | For | Management |

| 62856E104 — Meeting
Date: | MYOG — 5/4/2006 |
| --- | --- |
| Record
Date: | 3/24/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director M.R.
Bristow, MD, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Kirk K.
Calhoun | For | Yes | For | Management |
| 1 | Elect Director J. William
Freytag, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Judith A.
Hemberger, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Jerry T.
Jackson | For | Yes | For | Management |
| 1 | Elect Director Daniel J.
Mitchell | For | Yes | For | Management |
| 1 | Elect Director Arnold L.
Oronsky, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Michael J.
Valentino | For | Yes | For | Management |
| 2 | To ratify the selection by
the audit committee of the board of directors of Ernst & Young as
independent registered public accounting firm of the company for its fiscal
year ending December 31, 2006. | For | Yes | For | Management |

| 62855J104 — Meeting
Date: | MYGN — 1/6/2006 |
| --- | --- |
| Record
Date: | 11/15/2005 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Proposal to amend the 2003
Employee, Director and Consultant stock option plan to increase the number of
shares of common stock available for issuance thereunder by 1,200,000 shares. | For | Yes | Against | Management |

22

SEQ.=1,FOLIO='22',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
64124E106	NRGN	Neurogen
Corporation
Meeting
Date:	6/9/2006	Meeting
Type:	Annual
Record
Date:	4/13/2006

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Felix J.
Baker | For | Yes | For | Management |
| 1 | Elect Director Julian C.
Baker | For | Yes | For | Management |
| 1 | Elect Director Eran Broshy | For | Yes | For | Management |
| 1 | Elect Director Stephen R.
Davis | For | Yes | For | Management |
| 1 | Elect Director Stewart Hen | For | Yes | For | Management |
| 1 | Elect Director William H.
Koster | For | Yes | For | Management |
| 1 | Elect Director Jonathan S.
Leff | For | Yes | For | Management |
| 1 | Elect Director Craig
Saxton | For | Yes | For | Management |
| 1 | Elect Director John Simon | For | Yes | For | Management |
| 2 | To adopt an amendment to
the Neurogen Corporation 2000 non-employee directors stock option program to
increase the number of shares available for issuance under the program from
570,000 shares to 820,000 shares | For | Yes | For | Management |
| 3 | To adopt an amendment to
the amended and restated Neurogen Corporation 2001 stock option plan to
increase the number of shares available for issuance under the plan from
3,500,000 shares to 4,500,000 shares | For | Yes | For | Management |
| 4 | To ratify the appointment
by the board of directors of Pricewaterhousecoopers LLP as the independent
registered public accountatnts for the compay for the fiscal year ending
December 31, 2006 | For | Yes | For | Management |

| 654798503 — Meeting
Date: | NTMD — 5/17/2006 |
| --- | --- |
| Record
Date: | 4/3/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Argeris
Karabelas Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Robert S.
Cohen | For | Yes | For | Management |
| 1 | Elect Director Frank L.
Douglas, MD, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Zola
Horovitz, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Mark
Leschly | For | Yes | For | Management |
| 1 | Elect Director John W.
Littlechild | For | Yes | For | Management |
| 1 | Elect Director Joseph
Loscalzo, MD, Ph.D. | For | Yes | For | Management |
| 1 | Elect Director Davey S.
Scoon | For | Yes | For | Management |
| 2 | To adopt the amendment to
the company’s 2003 employee stock purchase plan | For | Yes | For | Management |
| 3 | To ratify the selection by
the audit committee of Ernst & Young LLP as the company’s independent
registered public accounting firm for the fiscal year ending December 31,
2006. | For | Yes | For | Management |

23

SEQ.=1,FOLIO='23',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
670009109	NOVN	Noven
Pharmaceuticals, Inc.
Meeting
Date:	5/23/2006	Meeting
Type:	Annual
Record
Date:	3/27/2006

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Sidney
Braginsky | For | Yes | For | Management |
| 1 | Elect Director John G.
Clarkson, MD | For | Yes | For | Management |
| 1 | Elect Director Donald A.
Denkhaus | For | Yes | For | Management |
| 1 | Elect Director Pedro P.
Granadillo | For | Yes | For | Management |
| 1 | Elect Director Robert G.
Savage | For | Yes | For | Management |
| 1 | Elect Director Robert C.
Strauss | For | Yes | For | Management |
| 1 | Elect Director Wayne P.
Yetter | For | Yes | For | Management |
| 2 | Proposal to ratify the
appointment of Deloitte & Touche LLP as the independent registered public
accounting firm for 2006. | For | Yes | For | Management |

| | OmniSonics
Medical Technologies, Inc. |
| --- | --- |
| Action by
Written Consent: | 7/8/2005 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director John L.
Brooks, III | For | No | None | Management |
| 1 | Elect Director Donald H.
Woods | For | No | None | Management |
| 1 | Elect Director Stephen
Bloch, MD | For | No | None | Management |
| 1 | Elect Director Robert J.
More | For | No | None | Management |
| 1 | Elect Director Bruce
Krattenmaker | For | No | None | Management |
| 1 | Elect Director David
Stewart | For | No | None | Management |
| 1 | Elect Director Richard
Ganz | For | No | None | Management |

| | OmniSonics
Medical Technologies, Inc. |
| --- | --- |
| Action by
Written Consent: | 10/17/2005 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Approve amendment to 2002
equity incentive plan | For | No | None | Management |
| 2 | Approve amendment to the
fourth amended and restated certificate of incorporation | For | No | None | Management |
| 3 | Approve amendment to the
fourth amended and restated stockholder rights agreement | For | No | None | Management |
| 4 | Approval of grant stock
options | For | No | None | Management |

24

SEQ.=1,FOLIO='24',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Company Name
	OmniSonics
Medical Technologies, Inc.
Action by
Written Consent:	7/10/2006

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director John L.
Brooks, III | For | Yes | For | Management |
| 1 | Elect Director Donald H.
Woods | For | Yes | For | Management |
| 1 | Elect Director Stephen
Bloch, M.D. | For | Yes | For | Management |
| 1 | Elect Director Robert J.
More | For | Yes | For | Management |
| 1 | Elect Director Bruce
Krattenmaker | For | Yes | For | Management |
| 1 | Elect Director David
Stewart | For | Yes | For | Management |
| 1 | Elect Director Richard
Ganz | For | Yes | For | Management |

| 68573C107 — Meeting
Date: | ORCH — 7/6/2006 |
| --- | --- |
| Record
Date: | 5/19/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director George H.
Poste | For | Yes | For | Management |
| 1 | Elect Director Nicole S.
Williams | For | Yes | For | Management |
| 2 | Proposal to ratify the
appointment of KPMG LLP as the company’s independent registered public
accounting firm for the fiscal year ending December 31, 2006 | For | Yes | For | Management |

| 68750U102 — Meeting
Date: | VITA — 7/25/2005 |
| --- | --- |
| Record
Date: | 4/28/2005 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Morris
Cheston, Jr. | For | Yes | For | Management |
| 1 | Elect Director David
Fitzgerald | For | Yes | For | Management |
| 1 | Elect Director Joseph L.
Harris | For | Yes | For | Management |
| 1 | Elect Director Antony
Koblish | For | Yes | For | Management |
| 1 | Elect Director Robert M.
Levande | For | Yes | For | Management |
| 1 | Elect Director Mary
Paetzold | For | Yes | For | Management |
| 1 | Elect Director Russell B.
Whitman | For | Yes | For | Management |
| 2 | Approval of proposed
amendment to the 1997 equity compensation plan to increase the number of
shares of Orthovita’s common stock available for issuance under the plan. | For | Yes | For | Management |

25

SEQ.=1,FOLIO='25',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
69329Y104	PDLI	PDL
Biopharma, Inc.
Meeting
Date:	6/14/2006	Meeting
Type:	Annual
Record
Date:	4/24/2006

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Karen A.
Dawes | For | Yes | For | Management |
| 1 | Elect Director Bradford S.
Goodwin | For | Yes | For | Management |
| 1 | Elect Director Mark McDade | For | Yes | For | Management |
| 2 | To ratify the appointment
of Ernst & Young LLP as the company’s independent registered public
accounting firm for the fiscal year ending December 31, 2006 | For | Yes | For | Management |

| 709754105 — Meeting
Date: | PPCO — 6/7/2006 |
| --- | --- |
| Record
Date: | 4/14/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Robert J.
Hennessey | For | Yes | For | Management |
| 1 | Elect Director John N.
Staniforth | For | Yes | For | Management |
| 2 | Ratification of the
appointment of Ernst & Young LLP as the independent registered public
accounting firm for the company for the current fisca year | For | Yes | For | Management |

| 717081103 — Meeting
Date: | PFE — 4/27/2006 |
| --- | --- |
| Record
Date: | 3/1/2006 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Michael S.
Brown | For | Yes | For | Management |
| 1 | Elect Director M. Anthony
Burns | For | Yes | For | Management |
| 1 | Elect Director Robert N.
Burt | For | Yes | For | Management |
| 1 | Elect Director W. Don
Cornwell | For | Yes | For | Management |
| 1 | Elect Director William H.
Gray III | For | Yes | For | Management |
| 1 | Elect Director Constance
J. Horner | For | Yes | For | Management |
| 1 | Elect Director William R.
Howell | For | Yes | For | Management |
| 1 | Elect Director Stanley O.
Ikenberry | For | Yes | For | Management |
| 1 | Elect Director George A.
Lorch | For | Yes | For | Management |
| 1 | Elect Director Henry A.
McKinnell | For | Yes | For | Management |
| 1 | Elect Director Dana G.
mead | For | Yes | For | Management |
| 1 | Elect Director Ruth J.
Simmons | For | Yes | For | Management |
| 1 | Elect Director William C.
Steere, Jr. | For | Yes | For | Management |
| 2 | Proposal to ratify the
appointment of KPMG LLP as independent registered public accounting firm for
2006 | For | Yes | For | Management |
| 3 | Management proposal to
amend company’s restate certificate of incorporation to eliminate
supermajority vote requirements and fair price provision | For | Yes | Against | Management |
| 4 | Shareholder proposal
relating to term limits for directors | Against | Yes | Against | Shareholder |
| 5 | Shareholder proposal requesting
reporting on pharmaceutical price restraint | Against | Yes | Against | Shareholder |
| 6 | Shareholder proposal
relating to cumulative voting | Against | Yes | Against | Shareholder |
| 7 | Shareholder proposal
requesting separation of roles of chairman and CEO | Against | Yes | For | Shareholder |
| 8 | Shareholder proposal
requesting a report on political contributions | Against | Yes | Against | Shareholder |
| 9 | Shareholder proposal
requesting a report on the feasibility of amending Pfizer’s corporate policy
on laboratory animal care and use | Against | Yes | Against | Shareholder |
| 10 | Shareholder proposal
requesitng justification for financial contributions which advance
animal-based testing methodologies | Against | Yes | Against | Shareholder |

26

SEQ.=1,FOLIO='26',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
71715B409	PHRM	Pharmion
Corporation
Meeting
Date:	6/8/2006	Meeting
Type:	Annual
Record
Date:	4/13/2006

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Elect Director Dr. Thorlef
Spickschen | For | Yes | For | Management |
| 1 | Elect Director John C.
Reed, Ph.D. | For | Yes | For | Management |
| 2 | To ratify the selection of
Ernst & Young LLP as Pharmion’s independent registered public accounting
firm for the fiscal year ending December 31, 2006 | For | Yes | For | Management |
| 3 | To approve the Pharmion
Corporation 2006 employee stock purchase plan | For | Yes | For | Management |

| | PHT
Corporation |
| --- | --- |
| Action by
Written Consent: | 12/27/2005 |

| # | Proposal | Mgt.
Recommends | Voted | Vote Cast | Sponsor |
| --- | --- | --- | --- | --- | --- |
| 1 | Authorize to enter into,
execute and deliver, and perform its obligations under a loan agreement | For | Yes | For | Management |

27

SEQ.=1,FOLIO='27',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-03.htm',USER='pbalakrishnan',CD='Aug 31 14:14 2006'

CUSIP	Symbol	Company Name
730694106	PTOP	Point
Therapeutics, Inc.
Meeting
Date:	6/20/2006	Meeting
Type:	Annual
Record
Date:	4/28/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Donald R.
Kiepert, Jr.	For	Yes	For	Management
1	Elect Director Timothy J.
Barberich	For	Yes	For	Management
1	Elect Director Richard J.
Benjamin	For	Yes	For	Management
1	Elect Director Thomas M.
Claflin II	For	Yes	For	Management
1	Elect Director Larry G.
Pickering	For	Yes	For	Management
1	Elect Director Daniel T.
Roble	For	Yes	For	Management
1	Elect Director William J.
Whelan, Jr.	For	Yes	For	Management

| | Raven
biotechnologies, Inc. |
| --- | --- |
| Action by
Written Consent: | 7/7/2005 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve amendment to
restated certificate	For	Yes	For	Management
2	Approve subsequent closing
investors per agreement	For	Yes	For	Management

| | Raven
biotechnologies, Inc. |
| --- | --- |
| Action by
Written Consent: | 7/28/2005 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve amendment to
restated certifcate	For	Yes	For	Management

| | Raven
biotechnologies, Inc. |
| --- | --- |
| Action by
Written Consent: | 9/23/2005 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve amendment to
restated certificate	For	Yes	For	Management

| | Raven
biotechnologies, Inc. |
| --- | --- |
| Action by
Written Consent: | 9/30/2005 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve financing	For	Yes	For	Management
2	Approve restated
certificate	For	Yes	For	Management
3	Approve plan amendment	For	Yes	For	Management

| | Raven
biotechnologies, Inc. |
| --- | --- |
| Action by
Written Consent: | 3/10/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve restated
certificate	For	Yes	For	Management
2	Approve waiver of any
default	For	Yes	For	Management

28

SEQ.=1,FOLIO='28',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-05.htm',USER='pbalakrishnan',CD='Aug 31 14:15 2006'

CUSIP	Company Name
	Raven
biotechnologies, Inc.
Action by
Written Consent:	4/20/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve amendment to
restated certificate	For	Yes	For	Management
2	Elect Director William R.
Rohn, Ph.D.	For	Yes	For	Management
3	Elect Director George F.
Schreiner, M.D., Ph.D.	For	Yes	For	Management

| 806605101 — Meeting
Date: | SGP — 5/19/2006 |
| --- | --- |
| Record
Date: | 3/20/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Thomas J.
Colligan	For	Yes	For	Management
1	Elect Director C. Robert
Kidder	For	Yes	For	Management
1	Elect Director Carl E.
Mundy, Jr.	For	Yes	For	Management
1	Elect Director Patricia F.
Russo	For	Yes	For	Management
1	Elect Director Arthur F.
Weinbach	For	Yes	For	Management
2	Ratify the designation of
Deloitte & Touche LLP to audit the books and accounts for 2006	For	Yes	For	Management
3	Approve amendments to
governing instruments to provide for the annual election of Directors	For	Yes	For	Management
4	Approve the directors
compensation plan	For	Yes	Against	Management
5	Approve the 2006 stock
incentive plan	For	Yes	For	Management
6	Shareholder proposal on
majority vote standard for the election of directors in certificate of
incorporation	Against	Yes	Against	Shareholder
7	Shareholder proposal on
majority vote on the greatest number of governance issues practicable.	Against	Yes	Against	Shareholder

| 812578102 — Meeting
Date: | SGEN — 5/19/2006 |
| --- | --- |
| Record
Date: | 3/21/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Clay B.
Siegall	For	Yes	For	Management
1	Elect Director Daniel F.
Hoth	For	Yes	For	Management
2	Proposal to ratify the
appointment of Pricewaterhousecoopers LLP as the independent registered
public accounting frim of the company for the fiscal year ending December 31,
2006	For	Yes	For	Management
3	Proposal to approve the
issuance and sale of 1,129,015 of common stock to entities affiliated with
Baker Brothers Investments for $5.25 per share pursuant to the stock purchase
agreement dated March 28, 2006	For	Yes	For	Management

29

SEQ.=1,FOLIO='29',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-05.htm',USER='pbalakrishnan',CD='Aug 31 14:15 2006'

CUSIP	Symbol	Company Name
81724Q107	SNMX	Senomyx,
Inc.
Meeting
Date:	5/24/2006	Meeting
Type:	Annual
Record
Date:	4/3/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Stephen A.
Block, Esq.	For	Yes	For	Management
1	Elect Director Michael E.
Herman	For	Yes	For	Management
1	Elect Director Mark
Leschly	For	Yes	For	Management
1	Elect Director Dennis F.
O’Brien	For	Yes	For	Management
1	Elect Director Jay M.
Short, Ph.D.	For	Yes	For	Management
1	Elect Director Kent Snyder	For	Yes	For	Management
1	Elect Christopher J.
Twomey	For	Yes	For	Management
2	To ratify the selection by
the audit committee of our board of directors of Ernst & Young LLP as our
independent auditors for the fiscal year ending December 31, 2006	For	Yes	For	Management

| 87959M106 — Meeting
Date: | TELK — 5/25/2006 |
| --- | --- |
| Record
Date: | 3/28/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Dr. Stefan
Ryser, Ph.D.	For	Yes	For	Management
1	Elect Director Robert W.
Frick	For	Yes	For	Management
1	Elect Director Mary Ann
Gray, Ph.D.	For	Yes	For	Management
2	To ratify the selection of
Ernst & Young LLP as independent registered public accounting firm of the
company for its fiscal year ending December 31, 2006	For	Yes	For	Management
3	To approve an amendment to
the company’s 2000 non-employee directors’ stock option plan to increase the
number of shares of common stock reserved for future issuance by 300,000
shares.	For	Yes	For	Management

30

SEQ.=1,FOLIO='30',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-05.htm',USER='pbalakrishnan',CD='Aug 31 14:15 2006'

CUSIP	Symbol	Company Name
88033G100	THC	Tenet
Healthcare Corporation
Meeting
Date:	5/12/2006	Meeting
Type:	Annual
Record
Date:	3/15/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Trevor
Fetter	For	Yes	For	Management
1	Elect Director Brenda J.
Gaines	For	Yes	For	Management
1	Elect Director Karen M.
Garrison	For	Yes	For	Management
1	Elect Director Edward A.
Kangas	For	Yes	For	Management
1	Elect Director J. Robert
Kerrey	For	Yes	For	Management
1	Elect Director Floyd D.
Loop, MD	For	Yes	For	Management
1	Elect Director Richad R.
Pettingill	For	Yes	For	Management
1	Elect Director James A.
Unruh	For	Yes	For	Management
1	Elect Director J. Mcdonald
Williams	For	Yes	For	Management
2	Proposal to ratify the
selection of KPMG LLP as independent registered public accountants for the
year ending December 31, 2006.	For	Yes	For	Management

| 88078L105 — Meeting
Date: | TRCA — 6/6/2006 |
| --- | --- |
| Record
Date: | 4/17/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Alexander
Barkas, Ph.D.	For	Yes	For	Management
1	Elect Director Dennis
Henner, Ph.D.	For	Yes	For	Management
1	Elect Director Mark
Leschly	For	Yes	For	Management
2	To ratify the selection of
Ernst & Young LLP as Tercica’s independent registered public accounting
firm for the fiscal year ending December 31, 2006	For	Yes	For	Management

| 881624209 — Meeting
Date: | TEVA — 7/19/2005 |
| --- | --- |
| Record
Date: | 6/20/2005 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	To receive and discuss the
company’s consolidated balance sheet and the consolidated statements of
income.	For	Yes	For	Management
2	To approve the Board of
Director’s recommendation that the cash dividend for the year ended December
31, 2004.	For	Yes	For	Management
3	To appoint Dr. Leora
(Rubin) Meridor as a statutory independent director for an additional term of
three years	For	Yes	For	Management
4	To elect Eli Hurvitz to
serve for an additional three-year term	For	Yes	For	Management
4	To elect Ruth Cheshin to
serve for an additional three-year term	For	Yes	For	Management
4	To elect Prof. Michael
Sela to serve for an additional three-year term	For	Yes	For	Management
4	To elect Harold Snyder to
serve for an additional three-year term	For	Yes	For	Management
5	To approve the purchase of
director’s and officer’s liability insurance for the the directors and
officers of the company.	For	Yes	For	Management
6	To approve the company’s
2005 omnibus long-term share incentive plan.	For	Yes	For	Management
7	To approve an amendment to
provisions of the company’s articles relating to the idemnifation of
directors and officers	For	Yes	For	Management
8	To approve an amendment to
the company’s articles that would increase the registered share capital of
the company	For	Yes	For	Management
9	To appoint Kesselman &
Kesselman, a member of Pricewaterhousecoopers International Ltd., as the
company’s independent registered public accounting firm and to determine
their compensation	For	Yes	For	Management

31

SEQ.=1,FOLIO='31',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-05.htm',USER='pbalakrishnan',CD='Aug 31 14:15 2006'

CUSIP	Symbol	Company Name
881624209	TEVA	Teva
Pharmaceutical Industries Ltd. ADR
Meeting
Date:	10/27/2005	Meeting
Type:	Special
Record
Date:	9/30/2005

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	To approve the issuance of
ordinary shares of Teva, pursuant to the agreement and plan of merger, dated
July 25, 2005, by and among Ivax Corporation, Teva and two wholly owned
subsidiaries of Teva, Ivory Acquisition Sub, Inc. and Ivory Acquisition Sub
II, Inc.	For	Yes	For	Management

| 881624209 — Meeting
Date: | TEVA — 5/4/2006 |
| --- | --- |
| Record
Date: | 3/27/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	To receive and discuss the
company’s consolidated blance sheet as of December 31, 2005 and the
consolidated statements of income for the year then ended.	For	Yes	For	Management
2	To approve the board of
directors’ recommendation that the cash dividend for the year ended December
31, 2005 be declared final.	For	Yes	For	Management
3	To appoint Prof. Gabriela
Shalev as a statutory independent director for an additional term of three
years.	For	Yes	For	Management
4	To elect the following
director to serve for a three-year term: Dr. Phillip Frost	For	Yes	For	Management
4	To elect the following
director to serve for a three-year term: Carlo Salvi	For	Yes	For	Management
4	To elect the following
director to serve for a three-year term: David Shamir	For	Yes	For	Management
5	To approve the purchase of
director’s and officer’s liability insurance for the
	directors and officers of
the company	For	Yes	For	Management
6	To approve an amendment to
section 60(E) of the company’s articles of
	association.	For	Yes	For	Management
7	To approve an increase in
the renumeration paid to directors of the company
	(other than the chairman
of the board)	For	Yes	For	Management
8	To appoint Kesselman &
Kesselman, as the independent registered public accounting firm and to
determine their compensation	For	Yes	For	Management

32

SEQ.=1,FOLIO='32',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-05.htm',USER='pbalakrishnan',CD='Aug 31 14:15 2006'

CUSIP	Symbol	Company Name
88338T104	THRX	Theravance,
Inc.
Meeting
Date:	4/26/2006	Meeting
Type:	Annual
Record
Date:	3/1/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director P. Roy
Vagelos, M.D.	For	Yes	For	Management
1	Elect Director Rick E.
Winningham	For	Yes	For	Management
1	Elect Director Julian C.
Baker	For	Yes	For	Management
1	Elect Director Jeffrey M.
Drazan	For	Yes	For	Management
1	Elect Director Robert V.
Gunderson, Jr.	For	Yes	For	Management
1	Elect Director Arnold J.
Levine, Ph.D.	For	Yes	For	Management
1	Elect Director Ronn C.
Loewenthal	For	Yes	For	Management
1	Elect Director Eve E.
Slater, M.D.	For	Yes	For	Management
1	Elect Director William H.
Waltrip	For	Yes	For	Management
1	Elect Director G.M.
Whitesides, Ph.D.	For	Yes	For	Management
1	Elect Director William D.
Young	For	Yes	For	Management
2	To ratify the selection by
the audit committee of the board of directors of Ernst & Young LLP as the
independent registered public accounting firm of Theravance, Inc. for its
fiscal year ending December 31, 2006.	For	Yes	For	Management

| | Therion
Biologics Corporation |
| --- | --- |
| Action by
Written Consent: | 1/4/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	To approve the certificate
of amendment to certificate of incorporation	For	No	None	Management
2	Increase in shares
reserved under 1998 stock plan	For	No	None	Management

| | Therox,
Inc. |
| --- | --- |
| Action by
Written Consent: | 9/15/2005 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Ray Larkin	For	No	None	Management

33

SEQ.=1,FOLIO='33',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-05.htm',USER='pbalakrishnan',CD='Aug 31 14:15 2006'

CUSIP	Symbol	Company Name
928551100	VVUS	Vivus,
Inc.
Meeting
Date:	6/14/2006	Meeting
Type:	Annual
Record
Date:	4/24/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Virgil A.
Place, MD	For	Yes	For	Management
1	Elect Director Leland F.
Wilson	For	Yes	For	Management
1	Elect Director Mark B.
Logan	For	Yes	For	Management
1	Elect Director Mario M.
Rosati	For	Yes	For	Management
1	Elect Director L.M.D.
Shortliffe, MD	For	Yes	For	Management
1	Elect Director Graham
Strachan	For	Yes	For	Management
2	Ratification of the appointment
of Ondenberg, Ullakko, Muranishi & Co. LLP as the independent public
auditors of the company for the fiscal year ending December 31, 2006	For	Yes	For	Management

| 928566108 — Meeting
Date: | VNUS — 5/25/2006 |
| --- | --- |
| Record
Date: | 4/3/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Kathleen D. Laporte	For	Yes	For	Management
1	Elect Lori M. Robson,
Ph.D.	For	Yes	For	Management
1	Elect Gregory T. Schiffman	For	Yes	For	Management
2	Ratification of
appointment of independent registered public accounting firm to be
Pricewaterhousecoopers LLP	For	Yes	For	Management

Action by
Written Consent:

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve an amendment of
the certificate of incorporation	For	Yes	For	Management
2	Approve the issuance of
securities	For	Yes	For	Management
3	Approve waiver of rights
of first refusal	For	Yes	For	Management

| | Xanthus
Pharmaceuticals, Inc. |
| --- | --- |
| Action by
Written Consent: | 1/27/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve an amendment to
the certificate of incorporation	For	Yes	For	Management
2	Approve an amendment to
the stockholder’s agreement	For	Yes	For	Management
3	Approve office of the
Company his or her true lawful agent with power of attorney	For	Yes	For	Management

34

SEQ.=1,FOLIO='34',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-05.htm',USER='pbalakrishnan',CD='Aug 31 14:15 2006'

CUSIP	Company Name
	Xanthus
Pharmaceuticals, Inc.
Action by
Written Consent:	2/3/2006

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Approve an amendment to
the certificate of incorporation	For	Yes	For	Management

| 98985T109 — Meeting
Date: | ZGEN — 6/15/2006 |
| --- | --- |
| Record
Date: | 4/10/2006 |

#	Proposal	Mgt. Recommends	Voted	Vote Cast	Sponsor
1	Elect Director Judith A.
Hemberger, Ph.D.	For	Yes	For	Management
1	Elect Director David I.
Hirsh, Ph.D.	For	Yes	For	Management
1	Elect Director David H.
Maccallum,	For	Yes	For	Management
1	Elect Director Kurt Anker
Nielsen	For	Yes	For	Management
2	Approval of 2001 stock
incentive plan	For	Yes	For	Management
3	Appointment of
Pricewaterhousecoopers LLP	For	Yes	For	Management

35

SEQ.=1,FOLIO='35',FILE='C:\JMS\pbalakr\06-18934-1\task1346307\18934-1-bi-05.htm',USER='pbalakrishnan',CD='Aug 31 14:15 2006'

*SIGNATURES*

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)
By (Signature and Title)*
	(Daniel Omstead, President)
	/s/ Daniel Omstead
Date	8/31/06

*Print the name and title of each signing officer under his or her signature.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\kumaresan\06-18934-1\task1345752\18934-1-jc.htm',USER='kdevaraj',CD='Aug 31 08:52 2006'